BioIVT Will Highlight Novel Hepatotoxicity Models at the 2021 SOT Annual Meeting and ToxExpo

Mar 11, 2021

Posted by BioIVT

Margaret Lwanga O’Shea joins BTI as business development specialist

Mar 10, 2021

Posted by labmovers

INFOGRAPHIC | The Time for Virtual Trials is Now

Mar 08, 2021

Posted by Veristat, LLC

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare Disease Day 2021

Mar 08, 2021

Posted by Veristat, LLC

New Podcast Series: Planning Your First IND

Mar 08, 2021

Thought Leadership Webinar with Roche – March 18, 2021

Mar 08, 2021